Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience.

Autor: Baxter, E.1, Gondara, L.2, Lohrisch, C.3, Chia, S.3, Gelmon, K.3, Hayes, M.4, Davidson, A.3, Tyldesley, S.1 styldesl@bccancer.bc.ca
Zdroj: Current Oncology. Jun2015, Vol. 22 Issue 3, p192-198. 7p. 6 Charts.
Databáze: Academic Search Ultimate